Download Document

CURRICULUM VITAE of
Masahiro Hiraoka
Professional experiences
1977-1978
1978-1979
1979-1980
1984-1987
1987-1988
1988-1989
1989-1991
1992-1995
1995-present
2006-2010
2007-2009
2008-2013
2012-present
Resident at Department of Radiology, Faculty of Medicine, Kyoto
University
Resident at Division of Radiation Oncology, Department of Radiology,
Kawasaki Medical University
Clinical staff at Division of Radiation Oncology, Department of Radiology,
Kawasaki Medical University
Assistant Professor, Department of Radiology, Faculty of Medicine, Kyoto
University
Visiting Assistant Professor, Department of Radiation Oncology, Stanford
University
Assistant Professor, Department of Radiology, Faculty of Medicine, Kyoto
University
Instructor, Department of Radiology, Faculty of Medicine, Kyoto
University
Associate Professor, Department of Radiology, Faculty of Medicine, Kyoto
University
Professor and Chairman, Department of Radiation Oncology &
Image-applied Therapy, Kyoto University Graduate School of Medicine
Director, Kyoto University Nanomedicine Merger Education Unit
Director, Kyoto University Hospital Cancer Center
Deputy Dean, Kyoto University Graduate School of Medicine
Vice-director, Socio-academic collaboration office of Kyoto University
Academic society activities
President
Federation of Asian Organizations for Radiation Oncology (FARO)
Japanese Board of Cancer Therapy
Japanese Society of Radiation Oncology
Vice-president
1
Asian Society of Hyperthermic Oncology
Executive Board members
The Japanese Association for Molecular Targeting Therapy of Cancer
Japanese Society of Molecular Imaging
Japan Society of Breast Cancer
Japan radiological Society
Editor-in-Chief
International Journal of Clinical Oncology
Breast Cancer
Associate Editor
Cancer Science
Awards
2008 Award of Minister of Economy, Trade and Industry for “Development of
High-precision Radiotherapy System”
2008 An Award of Japan Society of Mechanical Engineering
2009 Prize of Komei-Nakayama Award of Japan Society of Clinical Oncology
2013 Prizes for Science and Technology of the Commendation for Science and
Technology by the Minister of Education, Culture, Sports, Science and
Technology.
Publication (2013-present)
Hamaji M, Chen F, Matsuo Y, Ueki N, Hiraoka M, Date H. Treatment and prognosis of
isolated local relapse after stereotactic body radiotherapy for clinical stage I non-small cell
lung cancer: importance of salvage surgery. J Thorac Oncol. 2015 Aug 26.
Onimaru R, Shirato H, Shibata T, Hiraoka M, Ishikura S, Karasawa K, Matsuo Y, Kokubo M,
Shioyama Y, Matsushita H, Ito Y, Onishi H. Phase I study of stereotactic body radiation
therapy for peripheral T2N0M0 non-small cell lung cancer with PTV<100cc using a
continual reassessment method (JCOG0702). Radiother Oncol. 2015 Jul 29. pii:
S0167-8140(15)00360-6.
2
Hirata K, Nakamura M, Yoshimura M, Mukumoto N, Nakata M, Ito H, Inokuchi H, Matsuo
Y, Mizowaki T, Hiraoka M. Dosimetric evaluation of the Acuros XB algorithm for a 4MV
photon beam in head and neck intensity-modulated radiation therapy. J Appl Clin Med Phys.
2015 Jul 8;16(4):5222.
Tanaka S, Harada H, Hiraoka M. A novel method to visually determine the intracellular pH
of xenografted tumor in vivo by utilizing fluorescent protein as an indicator. Biochem
Biophys Res Commun. 2015 Sep 4;464(4):1151-6.
Nakamura M, Takamiya M, Akimoto M, Ueki N, Yamada M, Tanabe H, Mukumoto N,
Yokota K, Matsuo Y, Mizowaki T, Kokubo M, Hiraoka M. Target localization errors from
fiducial markers implanted around a lung tumor for dynamic tumor tracking. Phys Med.
2015 Jul 9. pii: S1120-1797(15)00152-0.
Inokuchi H, Mizowaki T, Norihisa Y, Takayama K, Ikeda I, Nakamura K, Nakamura M,
Hiraoka M. Clinical effect of multileaf collimator width on the incidence of late rectal
bleeding after high-dose intensity-modulated radiotherapy for localized prostate carcinoma.
Int J Clin Oncol. 2015 Jul 12. [Epub ahead of print]
Mizowaki T, Norihisa Y, Takayama K, Ikeda I, Inokuchi H, Nakamura K, Kamba T, Inoue T,
Kamoto T, Ogawa O, Hiraoka M. Long-term outcomes of intensity-modulated radiation
therapy combined with neoadjuvant androgen deprivation therapy under an early salvage
policy for patients with T3-T4N0M0 prostate cancer. Int J Clin Oncol. 2015 Jul 4. [Epub
ahead of print]
Nakamura M, Akimoto M, Ono T, Nakamura A, Yano S, Nakata M, Itasaka S, Mizowaki T,
Shibuya K, Hiraoka M. Interfraction positional variation in pancreatic tumors using daily
breath-hold cone-beam computed tomography with visual feedback. J Appl Clin Med Phys.
2015 Mar 8;16(2):5123.
Sato S, Miyabe Y, Takahashi K, Yamada M, Nakamura M, Ishihara Y, Yokota K, Kaneko S,
Mizowaki T, Monzen H, Hiraoka M. Commissioning and quality assurance of Dynamic
WaveArc irradiation. J Appl Clin Med Phys. 2015 Mar 8;16(2):5080.
Akimoto M, Nakamura M, Mukumoto N, Yamada M, Tanabe H, Ueki N, Kaneko S, Matsuo
Y, Mizowaki T, Kokubo M, Hiraoka M. Baseline correction of a correlation model for
3
improving the prediction accuracy of infrared marker-based dynamic tumor tracking. J Appl
Clin Med Phys. 2015 Mar 8;16(2):4896.
Kishi T, Matsuo Y, Ueki N, Iizuka Y, Nakamura A, Sakanaka K, Mizowaki T, Hiraoka M.
Pretreatment Modified Glasgow Prognostic Score Predicts Clinical Outcomes After
Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer. Int J
Radiat Oncol Biol Phys. 2015 Jul 1;92(3):619-26.
Ikeda I, Mizowaki T, Ono T, Yamada M, Nakamura M, Monzen H, Yano S, Hiraoka M.
Effect of intrafractional prostate motion on simultaneous boost intensity-modulated
radiotherapy to the prostate: A simulation study based on intrafractional motion in the prone
position. Med Dosim. 2015 May 19. pii: S0958-3947(15)00036-9.
Matsuo Y, Verellen D, Poels K, Mukumoto N, Depuydt T, Akimoto M, Nakamura M, Ueki
N, Engels B, Collen C, Kokubo M, Hiraoka M, de Ridder M. A multi-centre analysis of
treatment procedures and error components in dynamic tumour tracking radiotherapy.
Radiother Oncol. 2015 Jun;115(3):412-8.
Burghelea M, Verellen D, Poels K, Gevaert T, Depuydt T, Tournel K, Hung C, Simon V,
Hiraoka M, de Ridder M. Geometric Verification of Dynamic Wave Arc Delivery With the
Vero System Using Orthogonal X-ray Fluoroscopic Imaging. Int J Radiat Oncol Biol Phys.
2015 Jul 15;92(4):754-61.
Yamamoto M, Hokugo A, Takahashi Y, Nakano T, Hiraoka M, Tabata Y. Combination of
BMP-2-releasing gelatin/β-TCP sponges with autologous bone marrow for bone
regeneration of X-ray-irradiated rabbit ulnar defects. Biomaterials. 2015 Jul;56:18-25.
Inoue M, Yoshimura M, Sato S, Nakamura M, Yamada M, Hirata K, Sasaki M, Fujimoto T,
Ogura M, Hiraoka M. Improvement of registration accuracy in accelerated partial breast
irradiation using the point-based rigid-body registration algorithm for patients with
implanted fiducial markers. Med Phys. 2015 Apr;42(4):1904-10.
Gaowa A, Horibe T, Kohno M, Tabata Y, Harada H, Hiraoka M, Kawakami K. Enhancement
of anti-tumor activity of hybrid peptide in conjugation with carboxymethyl dextran via
disulfide linkers. Eur J Pharm Biopharm. 2015 May;92:228-36.
4
Hamaji M, Chen F, Matsuo Y, Kawaguchi A, Morita S, Ueki N, Sonobe M, Nagata Y,
Hiraoka M, Date H. Video-assisted thoracoscopic lobectomy versus stereotactic
radiotherapy for stage I lung cancer. Ann Thorac Surg. 2015 Apr;99(4):1122-9.
Hatanaka S, Miyabe Y, Tohyama N, Kumazaki Y, Kurooka M, Okamoto H, Tachibana H,
Kito S, Wakita A, Ohotomo Y, Ikagawa H, Ishikura S, Nozaki M, Kagami Y, Hiraoka M,
Nishio T. Dose calculation accuracies in whole breast radiotherapy treatment planning: a
multi-institutional study. Radiol Phys Technol. 2015 Jul;8(2):200-8.
Nakamura M, Akimoto M, Mukumoto N, Yamada M, Tanabe H, Ueki N, Matsuo Y,
Mizowaki T, Kokubo M, Hiraoka M. Influence of the correlation modeling period on the
prediction accuracy of infrared marker-based dynamic tumor tracking using a gimbaled
X-ray head. Phys Med. 2015 May;31(3):204-9.
Goto Y, Zeng L, Yeom CJ, Zhu Y, Morinibu A, Shinomiya K, Kobayashi M, Hirota K,
Itasaka S, Yoshimura M, Tanimoto K, Torii M, Sowa T, Menju T, Sonobe M, Kakeya H, Toi
M, Date H, Hammond EM, Hiraoka M, Harada H. UCHL1 provides diagnostic and
antimetastatic strategies due to its deubiquitinating effect on HIF-1α. Nat Commun. 2015
Jan 23;6:6153.
Hiraoka M, Inokuchi H. [Recent progress in radiation therapy]. Gan To Kagaku Ryoho.
2014 Dec;41(13):2535-8. Review. Japanese.
Ishihara Y, Sawada A, Nakamura M, Miyabe Y, Tanabe H, Kaneko S, Takayama K,
Mizowaki T, Kokubo M, Hiraoka M. Development of a dose verification system for
Vero4DRT using Monte Carlo method. J Appl Clin Med Phys. 2014 Nov 8;15(6):4961.
Kodaira T, Nishimura Y, Kagami Y, Ito Y, Shikama N, Ishikura S, Hiraoka M. Definitive
radiotherapy for head and neck squamous cell carcinoma: update and perspectives on the
basis of EBM. Jpn J Clin Oncol. 2015 Mar;45(3):235-43.
Nakajima A, Endo H, Okuyama H, Kiyohara Y, Kimura T, Kamiura S, Hiraoka M, Inoue M.
Radiation sensitivity assay with a panel of patient-derived spheroids of small cell carcinoma
of the cervix. Int J Cancer. 2015 Jun 15;136(12):2949-60.
Ueki N, Matsuo Y, Togashi Y, Kubo T, Shibuya K, Iizuka Y, Mizowaki T, Togashi K,
5
Mishima M, Hiraoka M. Impact of pretreatment interstitial lung disease on radiation
pneumonitis and survival after stereotactic body radiation therapy for lung cancer. J Thorac
Oncol. 2015 Jan;10(1):116-25.
Iizuka Y, Yoshimura M, Inokuchi H, Matsuo Y, Nakamura A, Mizowaki T, Hirano S,
Kitamura M, Tateya I, Hiraoka M. Recurrence patterns after postoperative radiotherapy for
squamous cell carcinoma of the pharynx and larynx. Acta Otolaryngol. 2015
Jan;135(1):96-102.
Ono T, Miyabe Y, Yamada M, Yokota K, Kaneko S, Sawada A, Monzen H, Mizowaki T,
Kokubo M, Hiraoka M. Development of an expanded-field irradiation technique using a
gimbaled x-ray head. Med Phys. 2014 Oct;41(10):101706.
Matsuo Y, Chen F, Hamaji M, Kawaguchi A, Ueki N, Nagata Y, Sonobe M, Morita S, Date
H, Hiraoka M. Comparison of long-term survival outcomes between stereotactic body
radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high
risk for lobectomy: A propensity score matching analysis. Eur J Cancer. 2014
Nov;50(17):2932-8.
Iizuka Y, Matsuo Y, Umeoka S, Nakamoto Y, Ueki N, Mizowaki T, Togashi K, Hiraoka M.
Prediction of clinical outcome after stereotactic body radiotherapy for non-small cell lung
cancer using diffusion-weighted MRI and (18)F-FDG PET. Eur J Radiol. 2014
Nov;83(11):2087-92.
Matsuo Y, Ueki N, Takayama K, Nakamura M, Miyabe Y, Ishihara Y, Mukumoto N, Yano S,
Tanabe H, Kaneko S, Mizowaki T, Monzen H, Sawada A, Kokubo M, Hiraoka M.
Evaluation of dynamic tumour tracking radiotherapy with real-time monitoring for lung
tumours using a gimbal mounted linac. Radiother Oncol. 2014 Sep;112(3):360-4.
Tsuruta Y, Nakata M, Nakamura M, Matsuo Y, Higashimura K, Monzen H, Mizowaki T,
Hiraoka M. Dosimetric comparison of Acuros XB, AAA, and XVMC in stereotactic body
radiotherapy for lung cancer. Med Phys. 2014 Aug;41(8):081715.
Fujimoto T, Monzen H, Nakata M, Okada T, Yano S, Takakura T, Kuwahara J, Sasaki M,
Higashimura K, Hiraoka M. Dosimetric shield evaluation with tungsten sheet in 4, 6, and
9MeV electron beams. Phys Med. 2014 Nov;30(7):838-42.
6
Koubuchi S, Takakura T, Nakamura M, Mizowaki T, Nakata M, Hiraoka M. Accuracy of
positional correction for the floor-mounted kV X-ray IGRT system in angled couch positions.
Radiol Phys Technol. 2014 Jul;7(2):373-8.
Shiinoki T, Sawada A, Ishihara Y, Miyabe Y, Matsuo Y, Mizowaki T, Kokubo M, Hiraoka M.
Dosimetric impact of gold markers implanted closely to lung tumors: a Monte Carlo
simulation. J Appl Clin Med Phys. 2014 May 8;15(3):4594.
Sasaki M, Nakata M, Inoue M, Sato S, Nakamura M, Fujimoto T, Tsuruta Y, Yano S,
Higashimura K, Yoshimura M, Hiraoka M. [Use of surgical clips to verify positional
accuracy in image-guided accelerated partial breast irradiation].Nihon Hoshasen Gijutsu
Gakkai Zasshi. 2014 May;70(5):467-75. Japanese.
Mampuya WA, Matsuo Y, Ueki N, Nakamura M, Mukumoto N, Nakamura A, Iizuka Y,
Kishi T, Mizowaki T, Hiraoka M. The impact of abdominal compression on outcome in
patients treated with stereotactic body radiotherapy for primary lung cancer. J Radiat Res.
2014 Sep;55(5):934-9.
Mukumoto N, Nakamura M, Yamada M, Takahashi K, Tanabe H, Yano S, Miyabe Y, Ueki N,
Kaneko S, Matsuo Y, Mizowaki T, Sawada A, Kokubo M, Hiraoka M. Intrafractional
tracking accuracy in infrared marker-based hybrid dynamic tumour-tracking irradiation with
a gimballed linac. Radiother Oncol. 2014 May;111(2):301-5.
Miki K, Hashimoto H, Inoue T, Matsuoka H, Harada H, Hiraoka M, Ohe K.
Sonication-induced formation of size-controlled self-assemblies of amphiphilic Janus-type
polymers as optical tumor-imaging agents. Small. 2014 Aug;10(15):3119-30.
Ogura K, Mizowaki T, Ishida Y, Hiraoka M. Dosimetric advantages of O-ring design
radiotherapy system for skull-base tumors. J Appl Clin Med Phys. 2014 Mar 6;15(2):4608.
Watanabe T, Mizowaki T, Arakawa Y, Iizuka Y, Ogura K, Sakanaka K, Miyamoto S, Hiraoka
M. Pineal parenchymal tumor of intermediate differentiation: Treatment outcomes of five
cases. Mol Clin Oncol. 2014 Mar;2(2):197-202. Epub 2013 Dec 23.
Sato M, Hiraoka M, Suzuki H, Sakima M, Mamun AA, Yamane Y, Fujita T, Yokoyama U,
7
Okumura S, Ishikawa Y. Protection of cardiomyocytes from the hypoxia-mediated injury by
a peptide targeting the activator of G-protein signaling 8. PLoS One. 2014 Mar
14;9(3):e91980.
Nakamura A, Itasaka S, Takaori K, Kawaguchi Y, Shibuya K, Yoshimura M, Matsuo Y,
Mizowaki T, Uemoto S, Hiraoka M. Radiotherapy for patients with isolated local recurrence
of primary resected pancreatic cancer. Prolonged disease-free interval associated with
favorable prognosis. Strahlenther Onkol. 2014 May;190(5):485-90.
Ono T, Miyabe Y, Yamada M, Shiinoki T, Sawada A, Kaneko S, Monzen H, Mizowaki T,
Kokubo M, Hiraoka M. Geometric and dosimetric accuracy of dynamic tumor-tracking
conformal arc irradiation with a gimbaled x-ray head. Med Phys. 2014 Mar;41(3):031705.
Ueki N, Matsuo Y, Nakamura M, Mukumoto N, Iizuka Y, Miyabe Y, Sawada A, Mizowaki T,
Kokubo M, Hiraoka M. Intra- and interfractional variations in geometric arrangement
between lung tumours and implanted markers. Radiother Oncol. 2014 Mar;110(3):523-8.
Ogura K, Mizowaki T, Arakawa Y, Ogura M, Sakanaka K, Miyamoto S, Hiraoka M. Initial
and cumulative recurrence patterns of glioblastoma after temozolomide-based
chemoradiotherapy and salvage treatment: a retrospective cohort study in a single institution.
Radiat Oncol. 2013 Apr 23;8:97.
Zhao T, Zhu Y, Morinibu A, Kobayashi M, Shinomiya K, Itasaka S, Yoshimura M, Guo G,
Hiraoka M, Harada H. HIF-1-mediated metabolic reprogramming reduces ROS levels and
facilitates the metastatic colonization of cancers in lungs. Sci Rep. 2014 Jan 23;4:3793.
Ogura K, Mizowaki T, Arakawa Y, Sakanaka K, Miyamoto S, Hiraoka M. Efficacy of
salvage stereotactic radiotherapy for recurrent glioma: impact of tumor morphology and
method of target delineation on local control. Cancer Med. 2013 Dec;2(6):942-9.
Nishio T, Shirato H, Ishikawa M, Miyabe Y, Kito S, Narita Y, Onimaru R, Ishikura S, Ito Y,
Hiraoka M. Design, development of water tank-type lung phantom and dosimetric
verification in institutions participating in a phase I study of stereotactic body radiation
therapy in patients with T2N0M0 non-small cell lung cancer: Japan Clinical Oncology
Group trial (JCOG0702). J Radiat Res. 2014 May;55(3):600-7.
8
Ikeda I, Mizowaki T, Norihisa Y, Takayama K, Kamba T, Inoue T, Nakamura E, Kamoto T,
Ogawa O, Hiraoka M. Long-term outcomes of dynamic conformal arc irradiation combined
with neoadjuvant hormonal therapy in Japanese patients with T1c-T2N0M0 prostate cancer:
case series study. Jpn J Clin Oncol. 2014 Feb;44(2):180-5.
Gaowa A, Horibe T, Kohno M, Sato K, arada H, Hiraoka M, Tabata Y, Kawakami K.
Combination of hybrid peptide with biodegradable gelatin hydrogel for controlled release
and enhancement of anti-tumor activity in vivo. J Control Release. 2014 Feb 28;176:1-7.
Sakanaka K, Matsuo Y, Nagata Y, Maki S, Shibuya K, Norihisa Y, Narabayashi M, Ueki N,
Mizowaki T, Hiraoka M. Safety and effectiveness of stereotactic body radiotherapy for a
clinically diagnosed primary stage I lung cancer without pathological confirmation. Int J
Clin Oncol. 2014 Oct;19(5):814-21.
Igaki H, Onishi H, Nakagawa K, Dokiya T, Nemoto K, Shigematsu N, Nishimura Y, Hiraoka
M; Japanese Society for Therapeutic Radiology and Oncology Health Insurance Committee.
A newly introduced comprehensive consultation fee in the national health insurance system
in Japan: a promotive effect of multidisciplinary medical care in the field of radiation
oncology--results from a questionnaire survey. Jpn J Clin Oncol. 2013 Dec;43(12):1233-7.
Nakamura M, Sawada A, Mukumoto N, Takahashi K, Mizowaki T, Kokubo M, Hiraoka
Effect of audio instruction on tracking errors using a four-dimensional image-guided
radiotherapy system. J Appl Clin Med Phys. 2013 Sep 6;14(5):255-64.
M.
Takakura T, Nakamura M, Shibuya K, Nakata M, Nakamura A, Matsuo Y, Shiinoki T,
Higashimura K, Teshima T, Hiraoka M. Effects of interportal error on dose distribution in
patients undergoing breath-holding intensity-modulated radiotherapy for pancreatic cancer:
evaluation of a new treatment planning method. J Appl Clin Med Phys. 2013 Sep
6;14(5):43-51.
Mampuya WA, Nakamura M, Matsuo Y, Ueki N, Iizuka Y, Fujimoto T, Yano S, Monzen H,
Mizowaki T, Hiraoka M. Interfraction variation in lung tumor position with abdominal
compression during stereotactic body radiotherapy. Med Phys. 2013 Sep;40(9):091718.
Akimoto M, Nakamura M, Mukumoto N, Tanabe H, Yamada M, Matsuo Y, Monzen H,
9
Mizowaki T, Kokubo M, Hiraoka M. Predictive uncertainty in infrared marker-based
dynamic tumor tracking with Vero4DRT. Med Phys. 2013 Sep;40(9):091705.
Kita Y, Imamura M, Mizowaki T, Norihisa Y, Yoshimura K, Hiraoka M, Ogawa O. Late
recurrence of nonseminomatous germ cell tumor successfully treated with
intensity-modulated radiation therapy. Jpn J Clin Oncol. 2013 Aug;43(8):835-7.
Ikeda I, Mizowaki T, Sawada Y, Nakata M, Norihisa Y, Ogura M, Hiraoka M. Assessment of
interfractional prostate motion in patients immobilized in the prone position using a
thermoplastic shell. J Radiat Res. 2014 Jan 1;55(1):168-74.
Kasuya G, Toita T, Furutani K, Kodaira T, Ohno T, Kaneyasu Y, Yoshimura R, Uno T, Yogi
A, Ishikura S, Hiraoka M. Distribution patterns of metastatic pelvic lymph nodes assessed
by CT/MRI in patients with uterine cervical cancer. Radiat Oncol. 2013 Jun 8;8:139.
Fukui N, Kageyama Y, Higashi Y, Kihara K, Kizaka-Kondoh S, Hiraoka M, Shinojima T,
Suzuki K, Oya M. Development of a novel interferon-α2b gene construct with a repetitive
hypoxia-inducible factor binding site and its suppressive effects on human renal cell
carcinoma cell lines in vitro. Int J Clin Oncol. 2014;19(3):497-504.
Iwata H, Masuda N, Ohno S, Rai Y, Sato Y, Ohsumi S, Hashigaki S, Nishizawa Y, Hiraoka
M, Morimoto T, Sasano H, Saeki T, Noguchi S. A randomized, double-blind, controlled
study of exemestane versus anastrozole for the first-line treatment of postmenopausal
Japanese women with hormone-receptor-positive advanced breast cancer. Breast Cancer Res
Treat. 2013 Jun;139(2):441-51.
Fujita M, Sasanuma H, Yamamoto KN, Harada H, Kurosawa A, Adachi N, Omura M,
Hiraoka M, Takeda S, Hirota K. Interference in DNA replication can cause mitotic
chromosomal breakage unassociated with double-strand breaks. PLoS One.
2013;8(4):e60043.
Mukumoto N, Nakamura M, Sawada A, Suzuki Y, Takahashi K, Miyabe Y, Kaneko S,
Mizowaki T, Kokubo M, Hiraoka M. Accuracy verification of infrared marker-based
dynamic tumor-tracking irradiation using the gimbaled x-ray head of the Vero4DRT
(MHI-TM2000). Med Phys. 2013 Apr;40(4):041706.
10
Sakanaka K, Mizowaki T, Sato S, Ogura K, Hiraoka M. Volumetric-modulated arc therapy
vs conventional fixed-field intensity-modulated radiotherapy in a whole-ventricular
irradiation: a planning comparison study. Med Dosim. 2013 Summer;38(2):204-8.
Yoshimura M, Itasaka S, Harada H, Hiraoka M. Microenvironment and radiation therapy.
Biomed Res Int. 2013;2013:685308.
Nakamura A, Shibuya K, Nakamura M, Matsuo Y, Shiinoki T, Nakata M, Mizowaki T,
Hiraoka M. Interfractional dose variations in the stomach and the bowels during breathhold
intensity-modulated radiotherapy for pancreatic cancer: Implications for a dose-escalation
strategy. Med Phys. 2013 Feb;40(2):021701.
Watanabe T, Monzen H, Hara M, Mizowaki T, Hiraoka M. Pharmacokinetic model of
myocardial (99m)Tc-sestamibi washout. Ann Nucl Med. 2013 Apr;27(3):279-84.
Kinoshita H, Shimizu Y, Mizowaki T, Takayama K, Norihisa Y, Kamoto T, Kamba T,
Hayashino Y, Hiraoka M, Ogawa O. Risk factors predicting the outcome of salvage
radiotherapy in patients with biochemical recurrence after radical prostatectomy. Int J Urol.
2013 Aug;20(8):806-11.
Matsugi K, Nakamura M, Miyabe Y, Yamauchi C, Matsuo Y, Mizowaki T, Hiraoka M.
Evaluation of 4D dose to a moving target with Monte Carlo dose calculation in stereotactic
body radiotherapy for lung cancer. Radiol Phys Technol. 2013 Jan;6(1):233-40.
Mampuya WA, Matsuo Y, Nakamura A, Nakamura M, Mukumoto N, Miyabe Y,
Narabayashi M, Sakanaka K, Mizowaki T, Hiraoka M. Differences in dose-volumetric
data between the analytical anisotropic algorithm and the x-ray voxel Monte Carlo algorithm
in stereotactic body radiation therapy for lung cancer. Med Dosim. 2013 Spring;38(1):95-9.
Matsuo Y, Onishi H, Nakagawa K, Nakamura M, Ariji T, Kumazaki Y, Shimbo M, Tohyama
N, Nishio T, Okumura M, Shirato H, Hiraoka M; Japan Conformal External Beam
Radiotherapy Group; Japan Society of Medical Physics; Japan Society of Medical Physics;
Japanese Society of Radiological Technology. Guidelines for respiratory motion
management in radiation therapy. J Radiat Res. 2013 May;54(3):561-8.
Utsunomiya S, Monzen H, Akimoto M, Mukumoto N, Ishihara Y, Shiinoki T, Nakamura M,
11
Miyabe Y, Sato S, Matsuo S, Hiraoka M. A feasibility study on reduction of the
entrance-surface dose to neonates by use of a new digital mobile X-ray system. Radiol Phys
Technol. 2013 Jan;6(1):157-61.
Ueki N, Matsuo Y, Shibuya K, Nakamura M, Narabayashi M, Sakanaka K, Norihisa Y,
Mizowaki T, Hiraoka M. Differences in the dose-volume metrics with heterogeneity
correction status and its influence on local control in stereotactic body radiation therapy for
lung cancer. J Radiat Res. 2013 Mar 1;54(2):337-43.
Mizowaki T, Takayama K, Nagano K, Miyabe Y, Matsuo Y, Kaneko S, Kokubo M, Hiraoka
M. Feasibility evaluation of a new irradiation technique: three-dimensional unicursal
irradiation with the Vero4DRT (MHI-TM2000). J Radiat Res. 2013 Mar 1;54(2):330-6.
12